Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 2821 AL 2835

Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

Yulug B, Altay O, Li X, Hanoglu L, Cankaya S, Lam S, Velioglu HA, Yang H, Coskun E, Idil E, Nogaylar R, Ozsimsek A, Bayram C, Bolat I, Oner S, Tozlu OO, Arslan ME, Hacimuftuoglu A, Yildirim S, Arif M, Shoaie S, Zhang C, Nielsen J, Turkez H, Borén J, Uhlén M, Mardinoglu A.

Transl Neurodegener. 2023 Jan 26;12(1):4. doi: 10.1186/s40035-023-00336-2.

The neuroimmune axis of Alzheimer's disease

Jorfi M, Maaser-Hecker A, Tanzi RE.

Genome Med. 2023 Jan 26;15(1):6. doi: 10.1186/s13073-023-01155-w.

Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease

Chaudhari V, Bagwe-Parab S, Buttar HS, Gupta S, Vora A, Kaur G.

Neurotox Res. 2023 Jun;41(3):270-287. doi: 10.1007/s12640-023-00634-7. Epub 2023 Jan 27.

How does apolipoprotein E genotype influence the relationship between physical activity and Alzheimer's disease risk? A novel integrative model

de Frutos Lucas J, Sewell KR, García-Colomo A, Markovic S, Erickson KI, Brown BM.

Alzheimers Res Ther. 2023 Jan 27;15(1):22. doi: 10.1186/s13195-023-01170-4.

Type-2 Diabetes, Pancreatic Amylin, and Neuronal Metabolic Remodeling in Alzheimer's Disease

Leibold N, Bain JR, Despa F.

Mol Nutr Food Res. 2024 Jul;68(13):e2200405. doi: 10.1002/mnfr.202200405. Epub 2023 Feb 6.

Brain temperature in healthy and diseased conditions: A review on the special implications of MRS for monitoring brain temperature

Yulug B, Velioglu HA, Sayman D, Cankaya S, Hanoglu L.

Biomed Pharmacother. 2023 Apr;160:114287. doi: 10.1016/j.biopha.2023.114287. Epub 2023 Jan 27.

Etiology and Clinical Significance of Network Hyperexcitability in Alzheimer's Disease: Unanswered Questions and Next Steps

Samudra N, Ranasinghe K, Kirsch H, Rankin K, Miller B.

J Alzheimers Dis. 2023;92(1):13-27. doi: 10.3233/JAD-220983.

The gut microbiome in Alzheimer's disease: what we know and what remains to be explored

Chandra S, Sisodia SS, Vassar RJ.

Mol Neurodegener. 2023 Feb 1;18(1):9. doi: 10.1186/s13024-023-00595-7.

Research progress of PPARγ regulation of cholesterol and inflammation in Alzheimer's disease

Gu L, Ju Y, Hu M, Zheng M, Li Q, Zhang X.

Metab Brain Dis. 2023 Mar;38(3):839-854. doi: 10.1007/s11011-022-01139-6. Epub 2023 Feb 1.

Selenium-enriched foods and their ingredients: As intervention for the vicious cycle between autophagy and overloaded stress responses in Alzheimer's disease

Chen M, Wu Q, Zhu Z, Huang A, Zhang J, Bekhit AEA, Wang J, Ding Y.

Crit Rev Food Sci Nutr. 2024;64(19):6672-6685. doi: 10.1080/10408398.2023.2172547. Epub 2023 Feb 2.

Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer's disease?

D'Amelio M, Di Lazzaro V.

Brain. 2023 Jun 1;146(6):e43-e45. doi: 10.1093/brain/awad019.

Reply: Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer's disease?

Koch G, Martorana A.

Brain. 2023 Jun 1;146(6):e46-e47. doi: 10.1093/brain/awad020.

Clinical efficacy and safety of compound Congrong Yizhi Capsules on Alzheimer's disease in mainland China: A systematic review with trial sequential analysis and GRADE assessment

Wang Y, Wang N, Xu Z, Liu S, Liang X, Zhang Y, Jin X.

J Ethnopharmacol. 2023 Jun 12;309:116208. doi: 10.1016/j.jep.2023.116208. Epub 2023 Jan 31.

APOE4: A Culprit for the Vulnerability of COVID-19 in Alzheimer's Patients

Goyal A, Kushwah PS, Agrawal N, Pathak S.

Curr Neurovasc Res. 2023;20(1):162-169. doi: 10.2174/1567202620666230202140612.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias